The researchers found that the Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale part III score, off dopaminergic medication at 96 weeks, increased (worsened ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients. Weekly injections of the GLP-1 receptor agonist exenatide (Byetta, ...

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 study suggesting a potential role for GLP-1 agonists in PD.

The GLP-1 drug, exenatide, has no positive impact on the ... research team have confirmed high levels of compliance with the medication by the use of blood tests checking the levels of exenatide ...

For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...

A NEW SET OF TARIFFS BY THE TRUMP ADMINISTRATION WILL TAKE EFFECT, AND THEY COULD DRAMATICALLY CHANGE THE WAY YOU GET YOUR PRESCRIPTION MEDICATIONS. YEAH. SO UNDER THIS PLAN, MEXICO AND CANADA ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval ...

Objective–To investigate the effect of treatment with the glucagon-like peptide 1 receptor agonist exenatide on weight loss and metabolic parameters in obese nondiabetic women. Research Design ...

The waiver, announced by Secretary of State Marco Rubio, seemed to allow for the distribution of H.I.V. medications, but whether the waiver extended to preventive drugs or other services offered ...

If you need to fly with medication, you may have a moment of panic while packing, wondering whether you can take pills or liquid or injectable medicines on a plane or travel with prescription ...